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Parathyroid hormone-related protein (PTHrP) was originally identified as the tumor product responsible for humoral
hypercalcemia of malignancy. It is now known that PTHrP is produced by many normal tissues in which it appears to play
a role as a developmental regulatory molecule. PTHrP is a normal product of mammary epithelial cells, and recent
experiments in our laboratory have demonstrated that overexpression or underexpression of PTHrP in the murine
mammary gland leads to severe disruptions in its development. The nature of these phenotypes suggests that PTHrP acts
to modulate branching growth during mammary development by regulating mammary stromal cell function. We now
demonstrate that throughout mammary development, during periods of active ductal-branching morphogenesis, PTHrP is
produced by epithelial cells, whereas the PTH/PTHrP receptor is expressed on stromal cells. In addition, we show that
mammary stromal cells in culture contain specific binding sites for amino terminal PTHrP and respond with an increase in
intracellular cAMP. Finally, we demonstrate that the mammary mesenchyme must express the PTH/PTHrP receptor in
order to support mammary epithelial cell morphogenesis. These results demonstrate that PTHrP and the PTH/PTHrP
receptor represent an epithelial/mesenchymal signaling circuit that is necessary for mammary morphogenesis and that
stromal cells are a critical target for PTHrP’s action in the mammary gland. © 1998 Academic Press
Key Words: mammary gland development; branching morphogenesis; mammary mesenchyme; mammary stroma; tissue
recombination experiments.
INTRODUCTION
Parathyroid hormone-related protein (PTHrP) was ini-
tially discovered because of its pathogenic role in a com-
mon paraneoplastic syndrome known as humoral hypercal-
cemia of malignancy (HHM) (Wysolmerski and Broadus,
1994). It derives its name from the fact that its gene and the
parathyroid hormone (PTH) gene are both descended from a
common ancestor through a process of gene duplication
(Broadus and Stewart, 1994). As a result, the two genes
share sequence homology and structural characteristics
that allow amino-terminal species of PTH and PTHrP to
signal through the same receptor, termed the type I PTH/
PTHrP receptor (Ju¨ppner et al., 1991). Despite these simi-
larities, these two peptides have evolved to serve very
different functions. PTH is made solely by the parathyroid
chief cells and is secreted into the systemic circulation
where it functions as a classical peptide hormone regulating
calcium homeostasis. In contrast, PTHrP is made by a wide
variety of cell types, does not circulate, and appears to
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function as a local autocrine or paracrine factor influencing
cell growth and differentiation (Broadus and Stewart, 1994).
As noted above, amino-terminal PTHrP signals through a
seven-transmembrane-spanning, G-protein-coupled recep-
tor known as the type I PTH/PTHrP receptor (Ju¨ppner et al.,
1991). This receptor subserves the calcium-regulating func-
tions of PTH and PTHrP in classical PTH-target organs, but,
like PTHrP, is also widely expressed in tissues not involved
in calcium homeostasis (Orloff et al., 1989). In these sites
the receptor is often expressed in cells in close proximity to
those expressing PTHrP, suggesting that it also mediates
many of the normal physiologic functions of PTHrP (Lee
et al., 1995). However, it is also known that PTHrP is a
polyprotein which, through a series of posttranslational
processing steps, gives rise to several biologically active
peptides not containing the amino terminus (Broadus and
Stewart, 1994; Soifer et al., 1992; Wu et al., 1996). These
peptides presumably signal through distinct, but as yet
unidentified, receptors (Kovacs et al., 1996; Orloff et al.,
1996).
PTHrP’s role in mature organisms remains unclear, but
in recent years evidence has accumulated to suggest that
this peptide functions as an important developmental regu-
latory molecule (Dunbar et al., 1996; Philbrick et al., 1996).
In fact, they have been reported to be one of the earliest
peptide hormone/receptor pairs to be detected during
mouse development and appear to participate in the forma-
tion of parietal endoderm (Behrendsten et al., 1995;
deStolpe et al., 1993). Because PTHrP-knockout mice suffer
from a fatal form of chondrodysplasia (Karaplis et al., 1994),
the most widely studied aspect of PTHrP’s developmental
functions has been its role in regulating chondrocyte differ-
entiation during fetal bone development. In the absence of
PTHrP, chondrocytes within the fetal growth plate appear
to differentiate too rapidly, and the fetal bones ossify
prematurely (Amizuka et al., 1994; Karaplis et al., 1994). In
contrast, mice overexpressing PTHrP in chondrocytes are
born with a cartilaginous skeleton, resulting from a pro-
found delay in chondrocyte differentiation (Weir et al.,
1996). Recent studies have demonstrated that PTHrP acts
in a feedback loop with Indian Hedgehog and BMP’s, in a
pathway involved in controlling the rate at which imma-
ture chondrocytes progress through their program of differ-
entiation (Kretzschmar et al., 1997; Lanske et al., 1996;
Vortkamp et al., 1996).
Another site in which PTHrP has clearly been shown to
have an important developmental role is the mammary
gland. Soon after its discovery, PTHrP was noted to be
expressed in the pregnant and lactating mammary gland
and to be present in large quantities in milk (Budayr et al.,
1989; Thiede and Rodan, 1988). Its function during preg-
nancy and lactation is still unknown but more recent data
from transgenic models of PTHrP underexpression and
overexpression have shown that it participates in the regu-
lation of ductal branching morphogenesis during embryonic
development as well as during sexual maturation and early
pregnancy (Wysolmerski et al., 1996; 1998). In the absence
of PTHrP or the PTH/PTHrP receptor, mammary epithelial
buds form, but fail to initiate ductal branching morphogen-
esis. Instead, the fetal epithelial cells degenerate and mam-
mary glands do not form (Wysolmerski et al., 1998). Over-
expression of PTHrP or PTH within the mammary gland
also perturbs ductal branching morphogenesis (Wysolmer-
ski et al., 1996). In this case, an excess of PTHrP results in
severe defects in ductular proliferation and side branching
during puberty and the inhibition of terminal ductule
formation during early pregnancy. Hence, amino-terminal
PTHrP, acting through the PTH/PTHrP receptor, appears to
contribute to the regulation of ductal branching morpho-
genesis at several different stages of mammary develop-
ment.
Like many other epithelial organs, the mammary gland is
dependent on the sequential and reciprocal exchange of
information between epithelial cells and neighboring mes-
enchymal cells for its proper morphogenesis (Cunha and
Hom, 1996; Sakakura, 1991; Thesleff et al., 1995). These
epithelial–mesenchymal interactions are especially critical
for the regulation of ductal branching morphogenesis. The
studies cited above suggest that PTHrP might act to regu-
late this process during mammary development by serving
as an epithelial signal acting to regulate mammary stromal
cell function. In this study, we present data to support such
a role for PTHrP. We demonstrate that during periods of
active ductal branching morphogenesis, the PTHrP gene is
expressed in the mammary epithelium, and the PTH/
PTHrP receptor gene is expressed in mammary stroma. In
addition, we show that mammary stromal cells bind and
respond to amino-terminal PTHrP. Finally, we demonstrate
that the presence of the PTH/PTHrP receptor in mammary
mesenchyme is critical to the ability of the mesenchymal
cells to support the initiation of ductal growth.
MATERIALS AND METHODS
In Situ Hybridization
In situ hybridization was performed on 5-mm paraffin sections as
described previously (Wysolmerski et al., 1998). Probes corre-
sponded to a 349-bp genomic fragment of the mouse PTHrP gene
and a 238-bp cDNA fragment of the PTH/PTHrP receptor gene
(Weir et al., 1996). Sense and antisense probes were generated from
linearized fragments using an in vitro transcription kit (Promega,
Madison, WI) in the presence of [35S]UTP (1000 Ci/mmol, Amer-
sham, Life Science, Arlington Heights, IL). Before hybridization,
sections were dewaxed and rehydrated, treated with proteinase K (3
mg/ml in PBS for 17 min at room temperature) and acetylated with
0.25% acetic anhydride in the presence of 0.1 M triethanolamine/
0.9% NaCl (pH 8.0) for 10 min. Sections were then rinsed in 23
SSC and incubated for 30 min in 0.66% N-ethylmaleimide (Sigma
Chemical Co., St. Louis, MO) in 23 SSC, rinsed in 23 SSC,
dehydrated in graded alcohol, treated with chloroform for 5 min,
rehydrated, and then air-dried. The probes (1.5 3 107 cpm/ml) were
then hybridized to the samples for 17 h at 54°C in a humidified
chamber. Hybridization buffer consisted of 50% formamide, 10%
dextran sulfate, 13 Denhardt’s solution, 43 SSC, 250 mg/ml tRNA,
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100 mg/ml salmon sperm DNA, and 50 mM DTT. After hybridiza-
tion, sections were rinsed in 13 SSC and washed twice in 23
SSC/50% formamide for 5 min at 52°C, rinsed in 23 SSC, and
treated with 30 mg/ml RNase A in 23 SSC at 37°C for 30 min.
Following two rinses in 23 SSC, sections were again washed in 23
SSC/50% formamide at 52°C for 5 min, dehydrated through graded
ethanol, air-dried, and dipped in a mixture of NTB-2 (Kodak)
photographic emulsion and water and exposed at 4°C for 3 weeks.
After development of the emulsion, sections were counterstained
with hematoxylin and mounted for microscopic examination.
Preparation of Mammary Stromal Cell Cultures
Mammary epithelial and stromal cells were isolated using a
modification of a previously described procedure (Haslam and
Levely, 1985). Briefly, the No. 4 inguinal mammary glands were
dissected from 11- to 14-day pregnant CD-1 mice, minced with
razor blades, and incubated overnight at 37°C in a digestion buffer
containing DMEM/F12, 5% FBS, 0.2% dispase grade II, 0.2%
collagenase type III, 50 mg/ml gentamycin, 100 units/ml nystatin,
and 2.5 mg/ml amphoteracin B. Following digestion, the cells were
pelleted by centrifugation at 1500 rpm, washed with DMEM, and
then filtered through a 70-mm nitex mesh filter to remove mam-
mary epithelial organoids. To enrich the remaining cells for mam-
mary fibroblasts, we used the differential centrifugation method of
Voyles and McGrath (1976). The flow-through following filtration
was spun at 80g for 30 s to pellet epithelial cells, and the resulting
supernatant, containing the mammary fibroblasts, was removed
and plated in DMEM medium supplemented with 10% FBS, 50
mg/ml penicillin, 50 mg/ml streptomycin, 100 units/ml nystatin,
2.5 mg/ml amphoteracin B, and 5 mg/ml each insulin and hydrocor-
tisone. Finally, to remove any remaining epithelial cells, the
medium was changed 4 h after plating, and the resulting cultures of
mammary stromal cells were grown at 37°C in 5% CO2 for 5 days.
To assess the purity of the mammary stromal cultures, we
performed immunohistochemistry using anti-vimentin and anti-
keratin 14 and anti-keratin 8,18 antibodies as stromal cell and
epithelial cell markers, respectively. The anti-mouse vimentin
antibody is a monoclonal antibody and was purchased from Boeh-
ringer Mannheim (Indianapolis). The K14 antibody is an affinity-
purified rabbit polyclonal antibody and was a kind gift of Dr. D.
Roop (Houston, TX). The anti-keratin 8,18 antibody is a mouse
monoclonal and was purchased from Nova-Castra (Burlingame,
CA). Immunohistochemistry was performed using standard tech-
niques and primary antibody binding was detected using the Vector
Elite avidin–biotin kit (Vector Laboratories, Burlingame, CA) and
3, 39-diaminobenzidine as a chromagen. Slides were counterstained
using hematoxlyn.
RNA Isolation and RNase Protection Analysis
Total RNA was isolated from cells using Trizol reagent (Gibco,
Gaithersville, MD). RNase protection analysis was performed as
described previously (Daifotis et al., 1992) using 2 3 105 cpm of
labeled antisense cRNA probes corresponding to a 349-bp AvrII
PvuII genomic fragment of the mouse PTHrP gene and a 283-bp
Sau3a–PvuII fragment of the mouse PTH/PTHrP receptor gene. For
an internal standard, 5 3 104 cpm of labeled antisense probe
corresponding to a 220-bp Sau3a–Sau3a fragment of the mouse
cyclophilin gene was used.
Receptor Binding Assay
The receptor binding assays were performed as described previ-
ously (Orloff et al., 1992) using 30,000 cpm/well of 125I-labeled
[Tyr36]hPTHrP-(1–36) NH2 in a final volume of 0.15 ml/well in
24-well plates for 4 h at 4°C in the presence or absence of increasing
concentrations of competing unlabeled PTHrP(1–36).
cAMP Assay
Cells were grown to confluence in 12-well plates at 37°C in 5%
CO2. Prior to the experiment, the cells were washed once with
serum-free medium containing 0.1% BSA and then incubated with
serum-free medium/0.1% BSA with or without PTHrP (1–36) at
various concentrations and for various time periods. The medium
was then aspirated, and the cells were treated with ice cold 90%
n-propanol for 24 h at 270°C. The samples were then lyophilized,
and intracellular cAMP content was measured using a commer-
cially available RIA (Biomedical Technologies, Stoughton, MA).
Tissue Recombination Experiments
Mammary gland rudiments were dissected from E13 PTH/
PTHrP receptor knockout (ko) and wild-type (wt) embryos which
were identified by their genotype as determined by PCR as de-
scribed previously (Wysolmerski et al., 1998). The mammary
rudiments were incubated for 1.5 h in 1% Bacto-trypsin in
calcium–magnesium-free Hanks’ salt solution at 4°C. Following
neutralization of the enzyme with 10% fetal bovine serum in
DMEM, the epithelium and mesenchyme were teased apart with
watchmakers forceps. For PTH/PTHrP receptor knockout em-
bryos, the four possible tissue recombinants were prepared with
mammary epithelium (MGE) and mammary mesenchyme (MGM)
from wt and ko mice: wt-MGM 1 wt-MGE, wt-MGM 1 ko-MGE,
ko-MGM 1 ko-MGE, and ko-MGM 1 wt-MGE (Cunha et al.,
1995). All tissue recombinants were transplanted beneath the renal
capsule of female athymic nude mouse hosts (see web site http://
mammary.nih.gov/tools/Cunha001/index.html for technical de-
tails). Following 1 month of growth, the grafts were harvested for
histological analysis (Cunha et al., 1995).
RESULTS
Expression of PTHrP and the PTH/PTHrP Receptor
during Ductal Morphogenesis
To begin to study the mechanisms by which PTHrP and
the PTH/PTHrP receptor regulate ductal growth and
branching morphogenesis, we examined their temporal and
spatial patterns of expression during fetal life, during sexual
maturation, and during early to mid-pregnancy, three peri-
ods of active ductal growth during mammary development.
We first sought to determine the temporal pattern of PTHrP
and PTH/PTHrP receptor mRNA expression in the whole
mammary gland by RNase protection analysis. Due to the
small size of the mammary glands, this analysis was not
possible for fetal time points and, therefore, we initiated
these studies by examining the temporal pattern of PTHrP
and PTH/PTHrP receptor expression in the preadolescent
gland (3-week-old virgin), during puberty (6-week-old vir-
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gin), and during early to mid-pregnancy (11 days postcoitus).
As shown in Fig. 1A, both PTHrP and the PTH/PTHrP
receptor are expressed in the mammary gland at each time
point. In addition, despite the dramatic changes in cellular
composition of the mammary gland at these different time
points, whole-gland levels of PTHrP and PTH/PTHrP recep-
tor mRNA expression remained relatively constant.
Our prior studies had suggested that, during embryonic
mammary development, PTHrP mRNA is expressed in
mammary epithelial cells and PTH/PTHrP receptor mRNA
is expressed in the mammary mesenchyme (Wysolmerski
et al., 1998). To determine if this pattern was also present
during the later stages of ductal morphogenesis, we first
took advantage of the directional growth of mammary
epithelial ducts during puberty. Prior to the initiation of
adolescence the mammary ducts occupy only a small por-
tion of one end of the mammary fat pad and, in response to
the hormonal stimulation of puberty, they grow toward the
opposite end of the mammary fat pad until they completely
fill out this stromal compartment. As a result of this growth
pattern, at the initiation of puberty, one can divide the
murine mammary gland into a proximal segment that
contains both epithelial and stromal components and a
distal segment that contains only stroma. As shown in Fig.
1B, the proximal component with both epithelial and stro-
mal cells, contains both PTHrP and PTH/PTHrP receptor
mRNA, but the distal component, that is stroma alone,
contains only PTH/PTHrP receptor mRNA. These data
suggest that PTHrP mRNA is expressed in the mammary
epithelium, and that PTH/PTHrP receptor mRNA is ex-
pressed within the fat pad stroma.
To examine this possibility directly, we next determined
the spatial localization of PTHrP and PTH/PTHrP receptor
mRNA expression by in situ hybridization during fetal life,
during adolescence and during early pregnancy. As shown
in Fig. 2, the PTHrP gene was expressed in epithelial cells
during periods of mammary ductal growth. At E12, we
found PTHrP expression to be very intense in the epithelial
cells of the embryonic mammary bud, especially in the cells
located peripherally, adjacent to the basement membrane
(Figs. 2A and 2B). At E18, at a time when the mammary bud
is elongating and initiating ductal branching morphogen-
esis, PTHrP expression continued to be intense and was
localized to mammary epithelial cells (Figs. 2C and 2D).
Once again, expression of the PTHrP gene was most obvi-
ous in epithelial cells located on the outer most layer of the
developing mammary ducts. These results are in agreement
with our previous findings that demonstrated PTHrP
mRNA expression in epithelial cells of the embryonic
mammary bud at E16 (Wysolmerski et al., 1998).
In the postnatal mammary gland (Figs. 2E through 2M),
PTHrP mRNA expression continued to be localized to
epithelial cells. However, overall, expression appeared to be
less intense than during fetal development and it appeared
to be restricted to epithelial cells located within terminal
end buds. End buds are specialized structures that form at
the leading edge of growing ducts, and they serve as the
sites of active cellular proliferation and differentiation
during phases of ductular proliferation (Daniel and Silber-
stein, 1987). As seen in Figs. 2E–2I, we found that, during
puberty, PTHrP mRNA was present in the epithelial cells of
end buds (Figs. 2E through 2G), but was undetectable in
FIG. 1. (A) Analysis of PTH and PTH/PTHrP receptor RNA in the
mammary gland during preadolescence, sexual maturation, and
pregnancy. 50 mg of total cellular RNA prepared from mammary
tissue from preadolescent (3-week-old virgin), adolescent (6-week-
old virgin), and pregnant (11 days postcoitus) mice was assayed for
PTHrP and PTH/PTHrP receptor expression by RNase protection
analysis. The murine cyclophilin RNA was included as a loading
control. Note that both PTHrP and the PTH/PTHrP receptor are
expressed in the mammary gland at each time point. (B) Analysis of
PTHrP and PTH/PTHrP receptor mRNA expression in proximal
and distal segments of preadolescent mammary glands. Mammary
glands from 3-week-old virgin mice were dissected and separated
into proximal and distal segments. Whole mount analysis con-
firmed that the proximal segment contained both epithelial and
stromal components, while the distal segment contained only
stroma (data not shown). 50 mg of total cellular RNA prepared from
either the proximal component (epithelial 1 fat pad) or the distal
component (fat pad) was assayed for PTHrP and PTH/PTHrP
receptor expression by RNase protection analysis. Note that the
proximal component with both epithelial and stromal cells con-
tains both PTHrP and the PTH/PTHrP receptor mRNA, but the
distal component, with stromal cells alone, contains only the
PTH/PTHrP receptor.
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epithelial cells of mature ducts (Figs. 2H and 2I). Specifi-
cally, the PTHrP mRNA signal appeared to localize to the
peripheral, or cap cells of the end buds, a pattern similar to
the peripheral location of the PTHrP signal seen during fetal
life. During early pregnancy, there appeared to be a very low
level of PTHrP mRNA expression within the epithelial
cells of developing lobuloalveolar units (Figs. 2J through
2M) but, similar to puberty, we could not detect PTHrP
mRNA in mature mammary ducts (data not shown). How-
ever, we did detect a similar pattern of epithelial PTHrP
expression in the occasional end bud we observed at the
periphery of early pregnant glands (data not shown). There-
fore, it appears that similar to embryonic life, in the
postnatal mammary gland, the major site of PTHrP expres-
sion is within epithelial cells. During puberty the PTHrP
gene is expressed most prominently in end buds, and during
early pregnancy there appears to be a low level of PTHrP
expression within the developing lobuloalveolar units.
In contrast to the epithelial pattern of PTHrP mRNA
expression, PTH/PTHrP receptor mRNA appeared to be
expressed in mammary stromal cells (Fig. 3). In the embry-
onic mammary gland, at E12, PTH/PTHrP receptor mRNA
was expressed throughout the ventral mesenchyme, includ-
ing the dense mammary mesenchyme (Figs. 3A and 3B). At
E18, when the mammary ducts had grown to make contact
with the mammary fat pad, PTH/PTHrP receptor mRNA
continued to be expressed in stromal cells enveloping the
growing mammary ducts (Figs. 3C and 3D). During puberty,
PTH/PTHrP receptor mRNA was expressed at a low level
throughout the mammary stroma, but the most prominent
PTH/PTHrP receptor expression was in stromal cells im-
mediately surrounding terminal end buds (Figs. 3E through
3G). This expression appeared to be most intense at the
neck regions of the end buds and decreased rapidly along the
more mature portions of the duct so that the majority of the
periductal stroma demonstrated a level of receptor mRNA
expression indistinguishable or just above the background
expression of the fat pad stroma (Figs. 3H and 3I). During
early to mid-pregnancy PTH/PTHrP receptor mRNA also
appeared to be expressed at a low level throughout the fat
pad stroma both within the periductal stroma and sur-
rounding the developing lobuloalveolar units (Figs. 3J
through 3M). However, the signal intensity was very low in
the pregnant tissue, and there was not striking pattern of
hybridization such as that seen during puberty. The excep-
tion to this diffuse low level of hybridization was in the
occasional gland with a few remaining end buds during
early pregnancy, where there was a strong signal within the
stroma surrounding the end buds (not shown).
Together, these studies demonstrate that during active
mammary ductular branching morphogenesis, PTHrP is
expressed by epithelial cells, and its receptor is expressed by
surrounding mesenchymal cells. In addition, it appears that
in the postnatal mammary gland, expression of the PTHrP
and the PTH/PTHrP receptor gene is most intense in
terminal end buds, regions of active proliferation and ductal
morphogenesis during puberty.
Mammary Stromal Cells Express Functional
PTH/PTHrP Receptors
Our in situ hybridization results demonstrate that the
PTH/PTHrP receptor is expressed in mammary stromal
cells and, therefore, suggest that these cells are a target for
PTHrP’s action in the mammary gland. To test this hypoth-
esis, we prepared primary cultures of both epithelial and
stromal cells from adult female mammary glands using
previously described protocols (Haslam and Levely, 1985;
Voyels and McGrath, 1976) and characterized their compo-
sition by immunocytochemistry, using anti-vimentin and
anti-keratin 14 and anti-keratin 8, 18 antibodies to identify
fibroblasts and epithelial cells, respectively. As defined by
the expression of vimentin and the lack of keratin expres-
sion, we were able to consistently prepare primary cultures
of mouse mammary stromal cells that were 90–95% pure, a
level of stromal cell enrichment comparable to that of
previous reports (data not shown, Haslam and Levely,
1985).
To determine whether stromal cells in culture continued
to express PTH/PTHrP receptor mRNA, total RNA was
prepared from our stromal cell cultures and from freshly
isolated mammary epithelial organoids and assayed for
steady-state levels of both PTHrP and PTH/PTHrP receptor
mRNA by RNase protection analysis. As shown in Fig. 4,
mammary stromal cells in culture contained PTH/PTHrP
receptor mRNA, but not PTHrP mRNA. In contrast, mam-
mary epithelial cells in freshly isolated organoids contained
PTHrP mRNA but no PTH/PTHrP receptor mRNA. These
results are identical to the results from our in situ analysis
and lend further support to the epithelial–mesenchymal
pattern of expression of PTHrP and the PTH/PTHrP recep-
tor in the mammary gland.
We next examined mammary stromal cells for specific
binding sites for amino-terminal PTHrP. For this purpose,
receptor binding assays were performed on intact cells,
using 125I-labeled PTHrP(1–36) as a ligand. These experi-
ments documented specific binding of 125I-labeled PTHrP-
(1–36) amide to mammary stromal cells with an apparent
Kd of 8.9 6 1.4 nM. Binding was specific, as it was effec-
tively competed with unlabeled PTHrP (1–36) amide (Fig.
5). The number of binding sites per cell, as determined by
Scatchard analysis, was calculated to be 126,000 6 13,000.
In addition, treatment of mammary stromal cells with
PTHrP(1–36) caused a increase in intracellular cAMP over
basal (Fig. 6). This cAMP response peaked at 2 min, as
shown in Fig. 6a, and showed a dose-dependent increase in
cAMP accumulation with maximal responses occurring
with 1026 and 1027 M PTHrP (Fig. 6b). Together, these
results indicate that mouse mammary stromal cells express
the PTH/PTHrP receptor both in vivo and in vitro, and
cultured stromal cells display high-affinity binding sites for
amino-terminal PTHrP at their cell surface and respond to
PTHrP with an increase in intracellular cAMP.
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The Mammary Mesenchyme Must Express the
PTH/PTHrP Receptor to Support the Outgrowth
of the Mammary Epithelium
We have previously reported that PTHrP and the PTH/
PTHrP receptor are required for the outgrowth of the
mammary epithelium during embryonic development. In
mice lacking either PTHrP or the PTH/PTHrP receptor,
mammary buds form but subsequent mammary develop-
ment fails. In the absence of PTHrP or its receptor, mam-
mary epithelial cells fail to undergo the initial stage of
branching morphogenesis known as the primary growth
spurt and, instead, degenerate and die (Wysolmerski et al.,
1998). These data, together with the expression patterns of
PTHrP and the PTH/PTHrP receptor and the presence of
functional PTH/PTHrP receptors in mammary stromal
cells, as described above, suggest that epithelial-derived
PTHrP, acting through stromal PTH/PTHrP receptors,
plays an important role in regulating ductal morphogenesis
during fetal life and perhaps also at later stages of develop-
ment (Wysolmerski et al., 1996; 1998). To test this hypoth-
esis directly, we performed a series of tissue recombination
and transplantation experiments using mammary epithelial
buds and mammary mesenchyme from wild-type and PTH/
PTHrP receptor-knockout embryos. In these experiments,
knockout and wild-type mammary epithelial buds and
mammary mesenchyme were recombined in the four pos-
sible combinations (see Table 1) and grown under the
kidney capsule of recipient females. We reasoned that if the
above hypothesis was valid, and PTHrP and the PTH/
PTHrP receptor do represent an epithelial–mesenchymal
signaling circuit, the PTH/PTHrP receptor-null phenotype
would be expected to segregate with mesenchymal tissue.
That is, receptor-knockout mesenchyme should be unable
to support the outgrowth of either receptor-knockout or
normal epithelial buds, but receptor-knockout epithelium
should be able to form ducts when combined with normal
mesenchyme.
Table 1 and Fig. 7 summarize the results of these experi-
ments. As expected, wild-type epithelial buds paired with
wild-type mammary mesenchyme (wt-MGE 1 wt-MGM)
consistently gave rise to a series of branched epithelial
ducts contained within a fatty stroma (see Fig. 7A). In
contrast, ductal outgrowth was never detected when PTH/
PTHrP receptor-knockout epithelial buds were paired with
PTH/PTHrP receptor-knockout mesencluyme (ko-MGE 1
ko-MGM, see Fig. 7B). These transplants gave rise to a fatty
stroma that was devoid of mammary epithelial cells, repro-
ducing the phenotype of the PTH/PTHrP receptor-knock-
out embryos. Recombinations consisting of PTH/PTHrP
receptor-knockout epithelium paired with wild-type mes-
enchyme (ko-MGE 1 wt-MGM) uniformly gave rise to
branched epithelial ducts within a fatty stroma (Fig. 7C).
However, although the receptor-knockout epithelial buds
consistently grew out and formed a rudimentary branching
ductal structure, the growth of the resulting ducts appeared
stunted compared with the ducts produced by wild-type
epithelial buds paired with wild-type mesenchyme. None-
theless, the PTH/PTHrP receptor-knockout epithelial cells
survived and had the capacity to initiate branching morpho-
FIG. 5. Binding of PTHrP(1–36) to mammary stromal cells in
culture. Receptor binding assays were performed with 125I-labeled
PTHrP(1–36) amide as a ligand for 4 h at 4°C with increasing
concentrations of unlabeled PTHrP(1–36) as competitor. The data
represent the mean 6 SE. A representative of three independent
experiments is shown.
FIG. 4. Analysis of PTHrP and PTH/PTHrP receptor expression in
freshly isolated mammary epithelial cells and mammary stromal
cells in culture. 50 mg of total cellular RNA from freshly isolated
mammary organoids and cultured mammary stromal cells was
assayed for both PTHrP and PTH/PTHrP receptor expression by
RNase protection analysis. Note that mammary stromal cells in
culture express the PTH/PTHrP receptor but not PTHrP mRNA,
whereas mammary epithelial cells express PTHrP mRNA but not
PTH/PTHrP receptor mRNA.
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genesis when paired with normal mesenchyme. As ex-
pected, similar to the results seen with knockout buds
paired with knockout mesenchyme, all recombinants com-
posed of wild-type epithelial buds paired with receptor-
knockout mesenchyme (wt-MGE 1 ko-MGM) lacked any
evidence of epithelial ductal outgrowth and consisted of
fatty stroma alone (see Fig. 7D), suggesting that PTH/
PTHrP receptor-knockout mesenchyme was unable to sup-
port the survival or morphogenesis of normal epithelial
cells in this transplant system. These results demonstrate
that the defects in mammary epithelial cell morphogenesis
and survival seen in the PTH/PTHrP receptor null mice
segregate with mesenchymal tissue and suggest that the
mesenchyme is a critical target for the actions of PTHrP
during mammary ductal morphogenesis.
DISCUSSION
Mammary gland morphogenesis is dependent on the
interplay of systemic endocrine signals and short-ranged
epithelial–mesenchymal interactions (Cunha, 1994; Sakakura,
1991). Although the morphological and endocrine aspects of
mammary development have been well defined, the para-
crine molecules and signaling mechanisms that are influ-
enced by systemic hormones and that regulate mammary
epithelial–mesenchymal interactions have only recently
begun to be understood (Friedmann and Daniel, 1996;
Kratochwil et al., 1996; Phippard et al., 1996; Hen-
nighausen and Robinson, 1998). Mammary ductal growth
during puberty is strictly dependent upon estrogens such as
estradiol signaling through the estrogen receptor-a, a con-
clusion derived from the analysis of estrogen receptor-
knockout (ERKO) mice (Korach, 1994). In addition, recent
analysis of ERKO/wild-type tissue recombinants have
shown that stromal estrogen receptors are especially impor-
tant for the effects of estrogens on ductal growth and
branching (Cunha et al., 1997). Several stromal cell factors
(some of which are estrogen-responsive) have now been
identified that appear to regulate epithelial cell morphogen-
esis and differentiation (Alexander et al., 1996; Jones et al.,
1996; Pollard and Henninghausen, 1994; Sympson et al.,
1994; Weil et al., 1995; Witty et al., 1995; Yang et al., 1995).
However, less is known about epithelial signals that are
involved in regulating stromal cell function during mam-
mary development. Prior experiments in transgenic mice
have suggested that amino-terminal PTHrP, acting through
the PTH/PTHrP receptor, might play a role in the
epithelial–mesenchymal interactions that govern mam-
mary ductal morphogenesis. In this report we provide a
series of observations lending further support to the notion
that PTHrP is an epithelial signal received by the mammary
mesenchyme that is critical for the mesenchyme’s ability
FIG. 6. cAMP response of mammary stromal cells in culture in response to PTHrP(1–36). (a) Time course of cAMP accumulation in
primary cultures of mouse mammary stromal cells following treatment with PTHrP(1–36). Mammary stromal cells were incubated for the
indicated times at 37°C in serum-free medium with or without 1027 M PTHrP(1–36), and intracellular cAMP was measured by
radioimmunoassay. Each point represents the mean 6 SE for duplicate samples from three separate experiments. (b) Dose-dependent effects
of PTHrP(1–36) on cAMP accumulation in mammary stromal cells. Mammary stromal cells were treated with varying concentrations of
PTHrP(1–36) for 2 min in serum-free medium, and intracellular cAMP was measured by radioimmunoassay. Each point represents the
mean 6 SE of three experiments each run in duplicate.
TABLE 1
Summary of Tissue Recombination Experiments
Mesenchyme Epithelium n
Stroma
only Ducts
wt wt 4 0 4
Receptor-ko Receptor-ko 4 4 0
wt Receptor-ko 2 0 2
Receptor-ko wt 3 3 0
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FIG. 7. Mesenchymal PTH/PTHrP receptor is necessary for the initiation of epithelial outgrowth. Mammary buds were dissected from
wild-type and PTH/PTHrP receptor knockout embryos at E13, and the epithelium and mesenchyme were separated and then recombined
in the four possible combinations and grown under the kidney capsule of recipient female mice for one month. Shown here are H&E-stained
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to support epithelial cell outgrowth and ductal branching
morphogenesis.
The first observation in support of this concept is that,
during periods of active ductal morphogenesis, PTHrP and
the PTH/PTHrP receptor are localized in epithelial and
mesenchymal cells, respectively. Mammary ductal mor-
phogenesis occurs in three distinct phases: during embryo-
genesis, during puberty and during early to mid-pregnancy.
At each of these stages, we have shown that PTHrP is
expressed in mammary epithelial cells and that the PTH/
PTHrP receptor is expressed in mammary stromal cells.
During embryogenesis, PTHrP mRNA was localized by in
situ hybridization to the epithelial cells of the mammary
bud and to the epithelial cells of rudimentary ducts as they
progressed through the initial round of ductal branching
morphogenesis from E16 to birth. The PTH/PTHrP receptor
gene was expressed in the mesenchymal cells surrounding
the mammary bud and in the mesenchyme that becomes
associated with the branching epithelial ducts as they grow
out into the developing mammary fat pad. This pattern of
epithelial/mesenchymal expression was also observed dur-
ing puberty. RNase protection analysis of PTHrP and PTH/
PTHrP receptor expression demonstrated that PTHrP is
found only within the portions of the mammary gland
containing epithelial cells, but that PTH/PTHrP receptor
mRNA is found both within the portions of the gland
containing epithelium as well as within the fat pad alone.
In situ hybridization demonstrated that this is due to the
expression of the PTHrP gene in epithelial cells and its
receptor gene in stromal cells. Furthermore, our in situ
results demonstrated that, during puberty, both genes are
most prominently expressed in terminal end buds. Interest-
ingly, reminiscent of the fetal pattern of expression, we
found that PTHrP mRNA appears to be localized to periph-
eral epithelial cells within the end buds which are known as
cap cells (Daniel and Silberstein, 1987). PTH/PTHrP recep-
tor message is found in the stromal cells immediately
adjacent to the cap cells and enveloping the terminal end
buds. Whereas we observed a low level of expression of the
PTH/PTHrP receptor gene in the stroma of the fat pad and
surrounding more mature ducts, we could not detect PTHrP
mRNA within the epithelial cells of the mature ducts.
During pregnancy there was a low level of PTHrP mRNA
expression in epithelial cells of the developing lobuloalveo-
lar units, and it appeared that the PTH/PTHrP receptor gene
was expressed throughout the stroma. These results are
consistent with the findings of Rakopolous et al. (1992) who
reported a diffuse, low level of PTHrP gene expression
within mammary epithelial cells during pregnancy in rats.
However, in our experiments, the levels of expression of
both genes were just above the detection limit of our in situ
hybridization technique and neither gene displayed an
obvious pattern of expression as seen within the end buds of
the adolescent gland. Despite this low level of hybridiza-
tion, we are confident that PTHrP is expressed in epithelial
cells and the PTH/PTHrP receptor is expressed in stromal
cells during pregnancy for we obtained exactly these results
using the more sensitive RNase protection assay. First, it is
clear from Fig. 1A that both genes continue to be expressed
on a whole gland level during pregnancy and, second, our
analysis of epithelial and stromal cells isolated from preg-
nant mammary glands (Fig. 4) demonstrates PTHrP but no
PTH/PTHrP receptor mRNA expression in epithelial cells
and PTH/PTHrP receptor but not PTHrP mRNA in stromal
cells.
The expression of PTHrP and its receptor in end buds in
an epithelial/mesenchymal pattern is logical if PTHrP af-
fects stromal function in a way that is important to the
overall regulation of morphogenesis because the terminal
end buds are the sites of active ductal growth and morpho-
genesis. During the embryonic development of the mam-
mary gland, the initial round of branching morphogenesis
occurs as a consequence of signaling between the mammary
epithelial bud and its surrounding mesenchyme (Sakakura,
1991). Likewise, during puberty, epithelial–mesenchymal
signaling at the terminal end bud influences the overall rate
of ductal proliferation as well as the branching pattern of
the growing duct system (Daniel and Silberstein, 1987;
Silberstein and Daniel, 1987; Silberstein et al., 1990).
Therefore the recapitulation of the embryonic pattern of
PTHrP and PTH/PTHrP receptor expression within the end
buds suggests that PTHrP signaling to mesenchymal cells is
most likely important to these processes during both phases
of mammary gland development. This concept is supported
sections through the resultant transplants after they were removed from beneath the kidney capsule. The left side of the figure represents
low-power views and the right side represents the high-power magnifications of the same sections displayed on the left. Each transplant
consists of a fragment of connective tissue containing varying amounts of fatty stroma, fibrous stroma, epidermal structures, and mammary
epithelium. (A) Representative transplant resulting from wild-type epithelium recombined with wild-type mesenchyme (wt-MGE 1
wt-MGM). Note the mammary epithelial ducts (higher power view on right) located within a mixture of fibrous and fatty stroma. The
structures at the lower left in the left-sided panel are hair follicles. (B) Representative transplant resulting from PTH/PTHrP receptor-
knockout epithelium (ko-MGE) paired with PTH/PTHrP receptor-knockout mesenchyme (ko-MGM). Note that there are no epithelial
ducts in this section, only fatty stroma. (C) Representative transplant resulting from wild-type mesenchyme (wt-MGM) paired with
PTH/PTHrP receptor-knockout epithelium (ko-MGE). Note that epithelial ducts are present within the stroma (higher magnification on
right), but that there are fewer ducts than in A. (D) Representative transplant resulting from knockout mesenchyme (ko-MGM) paired with
wild-type epithelium (wt-MGE). As in B, note the complete absence of epithelial ducts. The arrows in A and C indicate mammary epithelial
ducts. The scale bars in each panel demonstrate magnification as labeled.
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by the results of our experiments in transgenic animals
because disruption of the PTHrP gene results in the failure
of the initial round of branching outgrowth during embry-
onic development and overexpression of PTHrP in the
mammary gland in transgenic mice results in defects in
ductular proliferation and branching during adolescence
and pregnancy (Wysolmerski et al., 1996; 1998).
We did not detect PTH/PTHrP receptor expression in
epithelial cells by in situ hybridization during the time
points we examined. This is in contrast to reports in the
literature that have demonstrated PTH/PTHrP receptor
expression in cultured myoepithelial cells and in several
breast cancer cell lines (Birch et al., 1995; Ferrari et al.,
1993; Seitz et al., 1993). It may be that our in situ hybrid-
ization techniques cannot detect low levels of PTH/PTHrP
receptor mRNA in myoepithelial cells, or perhaps the
timing of PTH/PTHrP receptor expression in epithelial
cells is not represented in our sampling. Alternatively, the
presence of the receptor in myoepithelial cells may be
specific to cultured or transformed cells. Our results cannot
exclude that there may also be effects of PTHrP directly on
some epithelial cells. However, these results clearly do
demonstrate that the major location of PTH/PTHrP recep-
tor expression is the stroma.
The second observation in support of stromal cells as a
target of PTHrP’s effects in the mammary gland is the
ability of cultured stromal cells to express the PTH/PTHrP
receptor, to bind amino-terminal PTHrP with high affinity,
and to generate cAMP in response to PTHrP. These results,
combined with our findings that freshly isolated mammary
epithelial cells express the PTHrP gene but not the PTH/
PTHrP receptor gene, represent a correlation of the in situ
findings, in vitro, and underscore the concept that PTHrP,
produced by epithelial cells, acts on stromal cells. This
pattern is probably not unique to the mammary gland
because dermal fibroblasts and lung fibroblasts have also
been shown to respond to PTH and PTHrP, presumably via
the PTH/PTHrP receptor (Rubin et al., 1994; Shin et al.,
1997; Wu et al., 1987). Furthermore, the ability of these
cultured cells to retain their response to PTHrP now offers
us an experimental system with which to begin to study the
biological responses of stromal cells to PTHrP.
Our final observation in support of our working hypoth-
esis is the demonstration that the expression of the PTH/
PTHrP receptor in the mesenchyme is necessary for mam-
mary epithelial cell survival and ductal morphogenesis.
Using heterotypic tissue recombination and transplanta-
tion experiments, we have demonstrated that mammary
mesenchymal cells require functional PTHrP signaling for
these cells to support the survival and outgrowth of embry-
onic mammary epithelial cells. Unfortunately, experiments
using tissues from PTHrP knockout embryos were uninfor-
mative, but mesenchymal cells taken from PTH/PTHrP
receptor-knockout embryos were not able to support the
survival or growth of either receptor-knockout or wild-type
epithelial cells when these tissues were transplanted under
the kidney capsule of recipient mice. These results mirror
the failure of PTH/PTHrP receptor-knockout mammary
buds to undergo the initial, embryonic round of ductal
branching morphogenesis in vivo (Wysolmerski et al.,
1998). However, receptor-knockout epithelial cells were
able to survive and initiate branching morphogenesis when
recombined with normal mesenchyme, demonstrating di-
rectly that mesenchymal cells are critical targets of
PTHrP’s actions in promoting the outgrowth of the mam-
mary epithelial bud. It should be noted that although
receptor-knockout epithelium grew out and formed a rudi-
mentary duct system when combined with normal mesen-
chyme, the growth of the resultant epithelial ducts was
clearly not normal. These results may reflect the possibility
that myoepithelial cells express a low level of PTH/PTHrP
receptor which is below the detection limit of our in situ
hybridizations (discussed above) but which is, nonetheless,
important for the subsequent growth of the epithelial ducts
following the initiation of branching morphogenesis. It may
be that PTHrP signaling to the mesenchyme is sufficient to
initiate branching growth during fetal life but that subse-
quent ductular proliferation requires a more complicated
signaling cascade involving PTHrP’s actions on both stro-
mal and myoepithelial cells. To clarify this issue as well as
the temporal requirements for PTHrP during ductular mor-
phogenesis, it is likely that we will need to employ more
sensitive localization techniques and to generate either
conditional PTHrP-overexpressing or conditional PTHrP-
knockout mice.
Despite the caveats noted in the previous paragraph, in
the aggregate, it is clear that PTHrP’s actions on mammary
stromal cells have important consequences for ductal mor-
phogenesis. Much work has demonstrated that the stromal
mesenchyme plays a key role in determining the morphol-
ogy of the epithelial duct system as well as in regulating the
differentiation and functional activity of the mammary
epithelium (Cunha et al., 1995; Propper, 1973; Propper and
Gomot, 1973). Recent experiments have suggested that the
stromal regulation of epithelial function is complex. The
stroma secretes growth factors such as KGF, HGF/SF, IGF1,
and neuregulin which have been shown to regulate ductal
morphogenesis (Hadsell et al., 1996; Niranjan et al., 1995;
Ulich et al., 1994; Yang et al., 1995). In addition, the stroma
contributes to the extracellular matrix, whose composition
can have profound influences on epithelial behavior (Bissell
and Hall, 1987; Sakakura, 1991). Finally, the stroma appears
to be the principal source of matrix remodeling enzymes
that also have been shown to have important effects on
epithelial cell form, function, and survival (Alexander et al.,
1996; Sympson et al., 1994; Witty et al., 1995). All of these
molecules are potential downstream stromal effectors of
PTHrP’s actions on epithelial development, and we are
currently examining PTHrP’s effects on their expression in
our cultured mammary stromal cells. However, irrespective
of the exact stromal response to PTHrP, our results under-
score the truly reciprocal nature of the epithelial–
mesenchymal interactions at play during the regulation of
epithelial morphogenesis. Although stromal cells and their
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products are critical to the regulation of epithelial form and
function, it is clear that the epithelial cells participate in
the regulation of their own fate, for without epithelial
signals, such as PTHrP, the stromal cells are incompetent
to direct epithelial morphogenesis.
In summary, our experiments demonstrate that PTHrP
and the PTH/PTHrP receptor represent an epithelial/
mesenchymal circuit that is necessary for mammary mor-
phogenesis. Specifically, PTHrP produced by mammary
epithelial cells must signal through the PTH/PTHrP recep-
tor in mammary mesenchymal cells in order for the mes-
enchyme to support the initiation of mammary ductal
morphogenesis. PTHrP has also been implicated in the
development of other tissues that rely on epithelial/
mesenchymal interactions for their development, including
lung, teeth, and hair follicles (Philbrick et al., 1998). There-
fore, understanding PTHrP’s role in regulating stromal cell
function during the epithelial/mesenchymal interactions
that govern mammary development should allow us to
better understand the overall role of PTHrP in develop-
ment.
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